SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
10638398
Source:
http://linkedlifedata.com/resource/pubmed/id/10638398
Search
Subject
(
60
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0005508
,
umls-concept:C0012291
,
umls-concept:C0442118
,
umls-concept:C0524527
pubmed:issue
9
pubmed:dateCreated
2000-2-11
pubmed:abstractText
A comparison of the pharmacokinetic properties of two novel intranasal preparations of dihydroergotamine mesilate (DHEM) with a commercially available intranasal preparation.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/1256165
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Aerosols
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclodextrins
,
http://linkedlifedata.com/resource/pubmed/chemical/Dihydroergotamine
,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Combinations
,
http://linkedlifedata.com/resource/pubmed/chemical/Powders
,
http://linkedlifedata.com/resource/pubmed/chemical/Vasoconstrictor Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/beta-Cyclodextrins
,
http://linkedlifedata.com/resource/pubmed/chemical/betadex
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0031-6970
pubmed:author
pubmed-author:HooymansP MPM
,
pubmed-author:LohmanJ JJJ
,
pubmed-author:MerkusF WFW
,
pubmed-author:Ter BergJ WJW
,
pubmed-author:van der KuyP HPH
pubmed:issnType
Print
pubmed:volume
55
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
677-80
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:10638398-Absorption
,
pubmed-meshheading:10638398-Administration, Intranasal
,
pubmed-meshheading:10638398-Adult
,
pubmed-meshheading:10638398-Aerosols
,
pubmed-meshheading:10638398-Area Under Curve
,
pubmed-meshheading:10638398-Biological Availability
,
pubmed-meshheading:10638398-Chemistry, Pharmaceutical
,
pubmed-meshheading:10638398-Cross-Over Studies
,
pubmed-meshheading:10638398-Cyclodextrins
,
pubmed-meshheading:10638398-Dihydroergotamine
,
pubmed-meshheading:10638398-Drug Combinations
,
pubmed-meshheading:10638398-Female
,
pubmed-meshheading:10638398-Humans
,
pubmed-meshheading:10638398-Male
,
pubmed-meshheading:10638398-Middle Aged
,
pubmed-meshheading:10638398-Powders
,
pubmed-meshheading:10638398-Reference Values
,
pubmed-meshheading:10638398-Therapeutic Equivalency
,
pubmed-meshheading:10638398-Vasoconstrictor Agents
,
pubmed-meshheading:10638398-beta-Cyclodextrins
pubmed:year
1999
pubmed:articleTitle
Bioavailability of intranasal formulations of dihydroergotamine.
pubmed:affiliation
Department of Pharmacy, Laurentius Hospital, Roermond, The Netherlands. H.vanderKuy@lzr.nl
pubmed:publicationType
Journal Article
,
Clinical Trial
,
Comparative Study
,
Randomized Controlled Trial